主页 文献库文献详情
PMID: 42285576 已发表 · epublish 英语

Effect of a culturally adapted heart-healthy diet with phytosterols and/or krill oil on lipid-related outcomes in familial hypercholesterolaemia: protocol for a multicentre randomised controlled trial in Brazil.

BMJ open ·第 16 卷 ·第 6 期 ·2026-06-12

de Abreu-Silva EO, Vieira Machado RH, El Khouri FJ, Dos Santos FB, de Oliveira MAM, Kojima FCS, Peron RAN, Machado LS, Malvezzi GCS, Rodrigues LB, Veiga TS, Negrelli KDL, de Barros E Silva PGM, Santos RHN, Bersch-Ferreira ÂC, Carvalho AB, de Oliveira TM, Izar MC, Sampaio GR, Damasceno NRT, Rogero MM, Torres EAFDS, de Luca PV, Batista FAH, Cavalcanti AB, Marcadenti A

摘要

An affordable heart-healthy dietary approach is essential for the management of familial hypercholesterolaemia (FH); however, the optimal dietary pattern and the role of adjunctive nutrient supplementation remain uncertain. This study aims to evaluate the effects of the Brazilian Cardioprotective Diet (DICA Br), adapted from the Portfolio Diet, with or without phytosterol and/or krill oil supplementation in individuals with probable or definite FH according to the Dutch Lipid Clinic Network (Dutch MEDPED) criteria. The DICA-FH study is a national, multicentre, randomised, factorial, parallel-group, superiority, placebo-controlled clinical trial with a 1:1:1:1 allocation ratio. Participants aged ≥16 years receiving age-appropriate lipid-lowering therapy will be randomised into four groups: (1) adapted cardioprotective diet (DICA-FH) plus phytosterol placebo and krill oil placebo; (2) DICA-FH plus phytosterol 2 g/day and krill oil placebo; (3) DICA-FH plus phytosterol placebo and krill oil 2 g/day or (4) DICA-FH plus phytosterol 2 g/day and krill oil 2 g/day. All participants will undergo whole-genome sequencing and receive appropriate genetic counselling. Primary outcomes will be means of low-density lipoprotein cholesterol and lipoprotein(a) levels after 120 days. Secondary outcomes will include additional lipid biomarkers, adherence to protocol and adverse events. The planned sample size is 300 participants. Follow-up is expected to conclude in July 2026. This study was registered under CAAE 65549622.2.1001.0060 and received ethical approval from the Hcor Research Ethics Committee (approval number 5.805.072) and the Brazilian National Research Ethics Commission (CONEP; approval number 6.864.951). Written informed consent will be obtained from all participants prior to enrolment. The study findings will be disseminated through peer-reviewed publications, scientific conferences and channels aimed at the general public. NCT06331195.

关键词
Lipid disorders NUTRITION & DIETETICS Randomized Controlled Trial
文献信息
期刊
BMJ open
期刊简称
BMJ Open
ISSN
2044-6055
发表日期
2026-06-12
语言
英语
国家/地区
England
NLM ID
101552874
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]